How Do Emerging News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from How Do Emerging. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In How Do Emerging Today - Breaking & Trending Today

FDA Approves Secukinumab for Hidradenitis Suppurativa

Published: November 1, 2023

Secukinumab (Cosentyx) becomes the first IL-17A inhibitor, as well as the first drug since 2015, approved to treat adults with moderate to severe HS.

Source: hcplive.com

Related Topics:

Smitht Alexa KimballAlexa KimballJennifer HsiaoKunzmannk Jennifer HsiaoKunzmannk Matthew ZirwasNovartis CosentyxMatthew ZirwasHidradenitis SuppurativaDrug AdministrationKeck School Of MedicineHidradenitis Suppurativa Clinical ResponseKeck SchoolGreater ColumbusSecukinumab TreatmentPublished FebruaryPublished JuneHow Do EmergingFood And Drug AdministrationUs Fda